The Bionics Institute hosted seminar in October 2024. Nearly a year since we launched our clinical trial into a new treatment for Alzheimer’s disease, attendees got to get the latest on the clinical trial, get an insight into new related research, and hear about our PhD program.
The Bionics Institute are developing a new treatment to improve memory function in people with Alzheimer’s disease.
Developed by Bionics Institute researcher, Professor Kate Hoy, this new treatment, called Transcranial Magnetic Stimulation (TMS), uses magnetic pulses to alter brain activity.
View a recording of the seminar below:
- Head of Cognitive Therapeutics, Professor Kate Hoy: Investigating a new approach to treating Alzheimer’s disease
- Senior Clinical Research Fellow, Dr Oscar Murphy: Exploring how Alzheimer’s disease affects communication within the brain
- PhD Student, Ms Jacqueline Noonan: The PhD Journey
- TMS demonstration and Q&A
How TMS aims to help in Alzheimer’s disease
Alzheimer’s disease has been shown to interfere with important networks in the brain and this disruption in neural communication is linked to the cognitive difficulties experienced.
Transcranial Magnetic Stimulation (TMS) aims to improve brain function in people with Alzheimer’s disease by using magnetic pulses to alter brain activity.
This non-invasive approach has shown potential to restore healthy neural network function and improve memory in Alzheimer’s disease.
Our research team now aims to evaluate TMS in a larger clinical sample using a personalised treatment approach.
Event highlights
Professor Kate Hoy: Investigating a new approach to treating Alzheimer’s disease
Dr Oscar Murphy: Exploring how Alzheimer’s disease affects communication within the brain
Ms Jacqueline Noonan: The PhD Journey
TMS demonstration and Q&A
